These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9345351)

  • 1. The relevance of angiogenesis in benign and malignant epithelial tumors of the ovary: a quantitative histologic study.
    Brustmann H; Riss P; Naudé S
    Gynecol Oncol; 1997 Oct; 67(1):20-6. PubMed ID: 9345351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density.
    Emoto M; Iwasaki H; Mimura K; Kawarabayashi T; Kikuchi M
    Cancer; 1997 Sep; 80(5):899-907. PubMed ID: 9307190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray].
    Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis.
    Castellvi J; Garcia A; de la Torre J; Hernandez J; Gil A; Xercavins J; Ramón y Cajal S
    Hum Pathol; 2006 Jul; 37(7):883-9. PubMed ID: 16784989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
    Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R
    Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
    Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M
    Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphofunctional characteristics of microvessels in serous tumors of the ovaries].
    Mikhaleva LM; Moroz EA; Barkhina TG; Cherniaev AL; Samsonova MV; Solomatina AA
    Arkh Patol; 2005; 67(6):28-31. PubMed ID: 16405018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
    Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
    Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
    Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-1 and VEGF correlate with somatostatin expression and microvessel density in ovarian tumours.
    Hall GH; Turnbull LW; Bedford K; Richmond I; Helboe L; Atkin SL
    Int J Oncol; 2005 Nov; 27(5):1283-8. PubMed ID: 16211223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary.
    Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP
    Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.
    Schindl M; Schoppmann SF; Ströbel T; Heinzl H; Leisser C; Horvat R; Birner P
    Clin Cancer Res; 2003 Feb; 9(2):779-85. PubMed ID: 12576450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical chromosomal aberrations in borderline, benign, and malignant epithelial tumors of the ovary: correlation with p53 protein overexpression and Ki-67.
    Kohlberger PD; Kieback DG; Mian C; Wiener H; Kainz C; Gitsch G; Breitenecker G
    J Soc Gynecol Investig; 1997; 4(5):262-4. PubMed ID: 9360232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: an immunohistochemical and serological analysis.
    Darai E; Bringuier AF; Walker-Combrouze F; Fauconnier A; Couvelard A; Feldmann G; Madelenat P; Scoazec JY
    Gynecol Oncol; 1998 Oct; 71(1):122-7. PubMed ID: 9784332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.